VisualAbstract: Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer | 2 Minute Medicine
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis | SpringerLink
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma | NEJM
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis | Leukemia
Median overall survival of the patients following all o | Open-i
Frontiers | Treatment and survival analysis for 40-year SEER data on upper esophageal cancer
Survival (time to event) data: median survival times | The BMJ
VYXEOS® Efficacy - Phase 3 Trial Data vs 7+3 | VYXEOS® (daunorubicin and cytarabine)
Survival Analysis in R
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Kaplan-Meier survival analysis
survival - Time to event analysis - median (IQR) is <75% experience event - Cross Validated
Efficacy Data | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with
TTFields in Unresectable MPM: STELLAR Results in Practice - ILCN.org (ILCN/WCLC)
Ambiguities in computing the median survival time. - FAQ 44 - GraphPad
Cureus | A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience | Article
Biology | Free Full-Text | Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population
PADCEV® (enfortumab vedotin-ejfv) Efficacy in Patients with la/mUC
Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram
Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram
Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery | Anticancer Research
Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma | Anticancer Research
